People · Operator
Named in public records as an officer, director or promoter · active 2005–2014 · Pharmaceuticals, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals Inc | — | Pharmaceuticals | Series D+ | $209.0M | $247.2M | 2005 |
| Fluidigm Corp | — | Biotechnology | Series C | $111.0M | $3.1B | 2011 |
| Alexza Pharmaceuticals Inc. | — | Pharmaceuticals | Series B | $61.9M | $170.0M | 2009 |
| Veracyte, Inc. | — | Other Health Care | Series A | $22.1M | $258.2M | 2010 |
Samuel D. Colella at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Samuel D. Colella on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brook Byers | 1 | 13 |
| Fred Cohen | 1 | 12 |
| Brian G. Atwood | 1 | 8 |
| John Young | 1 | 7 |
| Patrick G. Enright | 1 | 7 |
| Brian Atwood | 1 | 6 |
| Jonathan T. Lord | 1 | 5 |
| Jesse I. Treu | 1 | 5 |
| JOHN A. YOUNG | 1 | 5 |
| James B. Tananbaum | 1 | 4 |
| Evan Jones | 1 | 4 |
| Michael Hunkapiller | 1 | 4 |
| Joseph L. Turner | 1 | 4 |
| Bonnie Anderson | 1 | 3 |
| SAMUEL COLELLA | 1 | 3 |
| Thomas B King | 1 | 3 |
| Shelly D. Guyer | 1 | 3 |
| J Kevin Buchi | 1 | 3 |
| Brook H Byers | 1 | 3 |
| Michael W. Michelson | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.